We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Premier Research Expands Clinical Research Facilities

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Premier Research Group Limited has announced the opening of new clinical research facilities located in Phoenix and Salt Lake City, increasing their testing facilities capacity by 50%.

“We are excited to be expanding our existing clinical research facilities to accommodate more phase 1 and outpatient studies,” stated Michael Kuss, Vice President, Analgesia.

Kuss continued, “These new facilities give us the capability to reach and house more study volunteers as well as successfully conduct phase 2 and 3 chronic pain, migraine, dysmenorrhea, vaccine, obesity and other models at all our sites.”

In addition to the full service CRO offerings, Premier Research owns and operates a network of clinical research centers designed to offer clinical site services from phase 1 proof of concept trials to phase 4 post-marketing trials primarily in the areas of healthy normal volunteers, acute and chronic pain, rheumatology, and neuroscience.

Each of the centers has multiple experienced investigators and full-time Premier Research staff that are medically trained and highly experienced.

Premier Research has been in the Phoenix market since 1993 and in Salt Lake City since 1999.

The Phoenix site is located in the Deer Valley Medical Center at 20414 N. 27th Avenue, Suite 200, and the Salt Lake City center is located at 3995 South 700 East #250.